Yixin Chen

Tregs with an MHC class II peptide–specific chimeric antigen receptor prevent autoimmune diabetes in mice

Jason S. Mitchell, M. Levings, P. Orban, 2023, The Journal of clinical investigation.

CD4+ T cells reactive to a hybrid peptide from insulin-chromogranin A adopt a distinct effector fate and are pathogenic in autoimmune diabetes.

T. Kaisho, Justin A. Spanier, B. Fife, 2024, Immunity.